Pediatric COVID-19

Pediatric COVID-19

Key Information

Appropriate treatment of concomitant pneumonia, respiratory failure, ARDS, sepsis, septic shock

Anticoagulation therapy should be risk stratified: see Clinical Management below.

More Information

This guideline will be continually updated as more evidence becomes available. 

Last updated: 5.5.22 

  • Remdesivir: now FDA approved for ages ≥ 28 days and ≥ 3 kg
  • Paxlovid: supply improved
  • Evusheld: 2nd referral option now available to Birds Eye Medical

See treatment guideline posted to COVID-19 microsite for updated list of references